Australian Super Pty LTD Bio Rad Laboratories, Inc. Transaction History

Australian Super Pty LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$418.69 - $503.0 $28.8 Million - $34.6 Million	-68,755 Reduced 21.24%	254,901 $122 Million
Q4 2022 Feb 01, 2023	SELL	$351.71 - $456.01 $24.4 Million - $31.6 Million	-69,338 Reduced 17.64%	323,656 $136 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $2.24 Million - $3.06 Million	5,427 Added 1.4%	392,994 $164 Million
Q2 2022 Jul 13, 2022	BUY	$463.67 - $597.16 $180 Million - $231 Million	387,567 New	387,567 $192 Million

459

19.6M

23.2K

37.4K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.1B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Australian Super Pty LTD with notifications on news.